AI Tool Comparison
Comparing as AI Medical Research & Clinical Decision SupportDoximity vs OpenEvidence
Compare features, pricing, pros & cons, and user ratings to decide which AI tool is best for your needs.
Doximity
VS
OpenEvidence
Verdict by Category
Detailed category analysis is not available for this comparison.
Detailed Comparison
Feature
Doximity
OpenEvidence
Pricing
FreemiumDoximity is free for all verified US healthcare professionals. Physicians, nurse practitioners, physician assistants, and medical students can access the full platform including Doximity Ask, Scribe, Dialer, secure messaging, and clinical news feed at no cost after NPI credential verification.
Doximity monetizes through B2B enterprise clients: pharmaceutical manufacturers, health systems, and medical recruiting firms pay to access and engage with Doximity's verified physician network through sponsored content, targeted outreach, and workflow integrations.
Enterprise pricing for health system and pharma clients is not publicly disclosed. Contact Doximity through doximity.com for enterprise partnership and B2B pricing inquiries.
FreemiumOpenEvidence is free for all verified US healthcare professionals. NPI verification is required to access the platform. The free tier includes full medical AI search, DeepConsult, Visits, Voice Mode, clinical calculators, and the AI-Integrated Doctor Dialer.
Enterprise pricing applies to health system deployments with EHR integration (Epic), multi-subspecialist AI agents, custom knowledge bases, priority compute, advanced visualization, and API licensing for clinical decision support integration into third-party platforms.
Contact OpenEvidence through openevidence.com for enterprise and health system pricing. Note: The platform withdrew from the EU and UK in April 2026 and is currently available to US healthcare professionals only.
Categories
AI Healthcare ToolsAI Research & Education ToolsAI Chatbots
AI Healthcare ToolsAI Research & Education ToolsAI Search Engines
Summary
America's largest physician network with free Clinical AI — Ask, Scribe, Dialer for 3M+ clinicians
AI clinical decision support free for verified physicians — 757K+ doctors, $12B valuation, peer-reviewed answers
Doximity Pros & Cons
Pros
- 85%+ of US physicians already on the platform — unmatched distribution advantage for AI clinical tools
- PeerCheck — 10,000-11,000 physician reviewers continuously validate AI answers, unique trust mechanism
- All AI tools completely free for verified US clinicians — zero budget barrier for adoption
- $644.9M FY2026 revenue, NASDAQ: DOCS — financially stable with strong margins (33% net income)
- Pathway Medical acquisition ($63M, Aug 2025) added physician-built clinical evidence dataset to Ask
- 300,000+ unique AI users in Q3 FY2026 — rapid AI adoption within existing physician network
- CEO declared 2026 an AI investment year — aggressive product roadmap with new physician-led AI agents
Cons
- OpenEvidence sued Doximity in June 2025 alleging reverse engineering of proprietary AI technology — legal risk
- AI products currently generate no direct revenue — monetization via B2B pharma/health system clients
- AI tools US-only — not available to international clinicians
- PeerCheck physician review relies on volunteer physician network — coverage can vary by specialty
- Doximity Scribe competes with established ambient documentation tools like DAX Copilot and Nabla with less clinical track record
- Enterprise AI pricing not publicly disclosed
OpenEvidence Pros & Cons
Pros
- Free for all verified US physicians — no cost barrier for individual clinician adoption
- 757,000+ verified physicians, 40%+ of US doctors use it daily — most widely adopted clinical AI in the US
- $12B valuation (January 2026), $250M Series D — Thrive Capital and DST Global backed
- Answers grounded exclusively in peer-reviewed literature — zero hallucination risk from non-medical sources
- 20M+ clinical consultations per month — proven real-world clinical usage at unprecedented scale
- Epic EHR integration live at Sutter Health — first public health system embedding of clinical AI in EHR
- DeepConsult AI agent handles multi-step clinical reasoning — goes beyond basic search to structured clinical analysis
Cons
- Withdrew from EU and UK in April 2026 — US-only availability limits international use
- Free tier requires verified NPI number — not accessible to non-US clinicians or students without credentials
- Impact on actual clinical decision-making scored only 1.95/4 in one study — physicians still cautious
- DeepConsult and enterprise features require institutional pricing
- Full chart-aware clinical support (reading patient records proactively) not yet available
- Only 20% of physicians fully support AI in clinical decision-making — adoption barriers remain